Skip to main content
Researchers in a lab examining a sample

Yellow, Blue & Purple Ribbon · Awareness month: May

Bladder Cancer

A bladder cancer diagnosis can bring questions about symptoms, treatment and everyday life. Learn what bladder cancer is, how it is found and treated, and how research is working toward better options for patients.

New U.S. bladder cancer cases expected in 2026
84,530
U.S. bladder cancer deaths expected in 2026
17,870
Approximate share of people with bladder cancer who are over 55
9 in 10

About

What Bladder Cancer Is

At NFCR, we believe understanding cancer is an important part of fighting it.

The bladder is an organ in the lower pelvis that stores urine. Bladder cancer develops when its cells grow out of control. Most cases are urothelial carcinoma, which starts in the cells lining the inside of the bladder.

Doctors describe cancer as non-invasive or invasive according to how deeply it has grown into the bladder wall. As it advances, bladder cancer can spread to other parts of the body.

Where bladder cancer begins and how it differs

Types of Bladder Cancer

Bladder cancers differ in the cells where they begin. The main distinction is between the common urothelial form and rarer diagnoses.

  • Urothelial carcinoma

    Begins in the cells lining the bladder and is the most common type.

  • Other bladder cancers

    Squamous cell carcinoma, adenocarcinoma, small cell carcinoma and sarcoma are less common in the U.S.

How deeply the cancer has grown: Non-invasive cancer is found in the inner bladder lining. Invasive cancer has grown into deeper layers of the bladder wall. Ask your care team how the type and extent of your cancer affect your options.

Behind every number is a person

By the numbers

These U.S. figures describe bladder cancer across large groups of people. They cannot predict an individual outcome.

  • 84,530New bladder cancer cases expected in the U.S. in 2026
  • 17,870Bladder cancer deaths expected in the U.S. in 2026
  • 1 in 28Approximate lifetime risk for men in the U.S.
  • 1 in 89Approximate lifetime risk for women in the U.S.
  • 9 in 10Approximate share of people with bladder cancer who are over 55
  • 79%Published five-year relative survival estimate for bladder cancer, all stages combined

U.S. estimates for 2026 · Source: American Cancer Society

Changes in urination to notice

Signs & Symptoms

Many bladder cancer symptoms involve changes in urination. Possible signs include:

  • Blood in the urine

    This is the most common symptom and may include blood clots.

  • Pain or burning

    Discomfort during urination is another change to discuss with a doctor.

  • Frequent urination

    You may need to urinate more often or wake repeatedly at night to go.

  • Difficulty passing urine

    You may feel the need to urinate but be unable to pass urine.

  • Back or pelvic pain

    Lower back pain, sometimes on one side, or pelvic pain can also occur.

Speak to a healthcare professional about blood in your urine or other changes in urination so the cause can be assessed.

Understand your risk of bladder cancer

Risk Factors and Prevention

Risk factors can include exposures and parts of your medical history. Discuss the factors that may apply to you with your doctor.

  • Smoking

    Tobacco use is a major bladder cancer risk factor.

  • Chemical exposure

    Certain workplace chemicals, including those used in dye, textile, rubber, leather, paint and printing industries, can increase risk.

  • Arsenic in drinking water

    Exposure is another recognized risk factor.

  • Chronic bladder problems

    Long-term irritation, stones or infections can affect risk.

  • Medical and family history

    Previous bladder or other urothelial cancer, family history, some genetic conditions and certain prior cancer treatments can increase risk.

Steps that may help lower risk: Avoid tobacco and get support to quit if you smoke. Follow workplace safety guidance to limit chemical exposure. Drink water and eat a balanced diet with fruit and vegetables as part of healthy habits. These steps do not eliminate the possibility of bladder cancer.

How bladder cancer is found — step by step

Screening and Diagnosis

Changes in urination can lead to tests that help your doctor find the cause. Your team can explain which tests you need.

  1. Urine tests

    A sample may be checked for abnormal cells when blood or other concerning changes are found.

  2. Cystoscopy

    A thin, lighted instrument lets the doctor look inside the bladder for unusual tissue.

  3. Biopsy

    A small tissue sample is examined under a microscope to establish whether it is cancer and identify its type.

Understanding your results: Ask what the tests showed, which type of bladder cancer you have and how far it has grown. Your care team can explain how these findings guide the next steps.

Explore your bladder cancer treatment options

Treatment

Bladder cancer can be treated with surgery or medicines. Your plan depends on the diagnosis and your individual circumstances.

  • Surgery

    An operation may be used to remove cancer. Ask your team what surgery would involve and how it could affect daily life.

  • Intravesical chemotherapy

    Medicine is delivered directly into the bladder through a catheter.

  • Systemic chemotherapy

    Medicine acts throughout the body rather than only inside the bladder.

  • Immunotherapy

    Treatment prompts an immune response against cancer. BCG is one form used inside the bladder in appropriate cases.

  • Targeted therapy

    Medicines act on specific features involved in cancer growth.

  • Clinical trials

    Studies test new treatment approaches. Ask whether a trial may fit your diagnosis and needs.

You don’t need to understand everything at once

What Happens After Diagnosis?

Take time to understand your results and what each option could mean for daily life. Your care team can help you plan for treatment, recovery and ongoing checks.

Bladder Cancer — A few steps can help

A few steps can help

  • Ask what type of bladder cancer you have and how far it has grown.
  • Ask for an explanation of your test results and report.
  • Discuss the purpose, benefits and side effects of each treatment.
  • Ask how treatment may affect daily life.
  • Ask whether a clinical trial or second opinion would be helpful.
  • Bring a trusted person and write down questions for appointments.

NFCR · redesign.nfcr.org

Researchers in a lab examining a sample
NFCR research on bladder cancer

The Future of Bladder Cancer Research

Understanding how cancer cells grow, resist immune attack and spread is an important part of developing better treatments. Our research portfolio brings together work on chromosome changes, cancer signaling and RNA fragments. These projects address questions across cancer types; their possible relevance to bladder cancer requires further research.

What NFCR Is Doing

We support research into cancer genetics, immune resistance and metastasis. Teresa Davoli and J. Silvio Gutkind investigate chromosome loss and immune resistance in oral cancer models, while Danny Welch and Isidore Rigoutsos study RNA fragments and cancer spread. These foundational projects may inform future research across cancers; they are not established bladder cancer treatments.

Scientists studying cancer genetics, immune resistance and metastasis in the research portfolio below
4
Collaborations represented: Davoli–Gutkind and Welch–Rigoutsos
2
Years Danny Welch led the NFCR Center for Cancer Metastasis, a program studying cancer spread across cancer types
2002–2018

The scientists working on this cancer

Explore scientists featured in our bladder cancer research portfolio and the broader biological questions their work addresses.

Teresa Davoli, Ph.D.

New York University School of Medicine

Studies chromosome changes and how they affect cancer’s ability to evade the immune system. Her collaboration with J. Silvio Gutkind uses oral cancer models to investigate loss of chromosome 9p.

J. Silvio Gutkind, Ph.D.

University of California San Diego, Moores Cancer Center

Investigates cancer signaling and immune resistance. With Teresa Davoli, he studies how chromosome 9p loss affects the immune response in oral cancer models, with potential relevance to other cancers.

Isidore Rigoutsos, Ph.D.

Thomas Jefferson University, Sidney Kimmel Cancer Center

Develops computational tools to study small RNA fragments. His collaboration with Danny Welch examines how these fragments may influence cancer spread.

Danny R. Welch, Ph.D.

University of Kansas Cancer Center

Studies the biological processes that allow cancer to spread, including mitochondrial genes and RNA fragments. His collaboration with Isidore Rigoutsos combines laboratory research with computational analysis.

Research makes cures possible

Every new discovery has the potential to change what we know about cancer — how it begins, how it spreads, how it can be detected, and how it can be treated.

Your support helps fund scientists working across cancer types to turn promising discoveries into life-saving options for patients.

Prefer to speak with someone? Call us to donate — 1-800-321-CURE.